Korea Institute of Oriental Medicine, Daejeon, Korea.
Acta Ophthalmol. 2010 Dec;88(8):e328-33. doi: 10.1111/j.1755-3768.2010.02027.x. Epub 2010 Nov 10.
To evaluate the efficacy and safety of acupuncture for ocular symptoms, tear film stability and tear secretion in dry eye patients.
This is a randomized, patient-assessor blinded, sham acupuncture controlled trial. Forty-two participants with defined moderate to severe dry eye underwent acupuncture treatment three times a week for 3 weeks. Seventeen standard points (GV23; bilateral BL2, GB14, TE23, Ex1, ST1 and GB20; and unilateral SP3, LU9, LU10 and HT8 on the left for men and right for women) with 'de qi' manipulation for the verum acupuncture group and seventeen sham points of shallow penetration without other manipulation for the sham group were applied during the acupuncture treatment. Differences were measured using the ocular surface disease index (OSDI), the visual analogue scale (VAS) of ocular discomfort, the tear film break-up time (BUT) and the Schimer I test with anaesthesia. In addition, adverse events were recorded.
There were no statistically significant differences between results on the OSDI, VAS, BUT or Schimer I tests from baseline between the verum and sham acupuncture groups. However, results from the within-group analysis showed that the OSDI and VAS in both groups and the BUT in the verum acupuncture group were significantly improved after 3 weeks of treatment. No adverse events were reported during this trial.
Both types of acupuncture improved signs and symptoms in dry-eye patients after a 4-week treatment. However, verum acupuncture did not result in better outcomes than sham acupuncture.
评估针刺治疗干眼患者眼部症状、泪膜稳定性和泪液分泌的疗效和安全性。
这是一项随机、患者评估者盲法、假针刺对照试验。42 名明确的中重度干眼患者每周接受针刺治疗 3 次,共 3 周。17 个标准穴位(GV23;双侧 BL2、GB14、TE23、Ex1、ST1 和 GB20;以及男性左侧 SP3、LU9、LU10 和 HT8,女性右侧 SP3、LU9、LU10 和 HT8)采用“得气”手法进行真针刺组,17 个假针刺组进行浅刺无其他手法的假针刺组。在针刺治疗过程中应用这些穴位。使用眼表面疾病指数(OSDI)、眼部不适视觉模拟量表(VAS)、泪膜破裂时间(BUT)和麻醉 Schimer I 试验来测量差异。此外,还记录了不良反应。
真针刺组和假针刺组在 OSDI、VAS、BUT 或 Schimer I 测试中,从基线开始的结果之间没有统计学上的显著差异。然而,组内分析结果表明,两组的 OSDI 和 VAS 以及真针刺组的 BUT 在治疗 3 周后均显著改善。在试验过程中未报告任何不良反应。
两种类型的针刺治疗均能改善干眼患者的症状和体征,经过 4 周的治疗。然而,真针刺并未比假针刺产生更好的效果。